the second pathway mediates/activates NLRP3 inflammasome through unclear mechanisms, promoting the initiation and progression of DKD mediated by the models of the potassium channel, lysosomal damage, as well as active oxygen cluster (65). Here, NLRP3 is linked to diabetic kidney disease.